No abstract

Aims: Natural products have been used as potentially important sources of novel antibacterials in combating pathogenic Staphylococcus aureus isolates, a major problem around the world. In this study, we aimed to investigate the antibacterial effects of pinocembrin (PNCB) against Staph. aureus pneumonia in a murine model and its influence on the production of Staph. aureus a-haemolysin (Hla). Methods and Results:The in vitro activities of PNCB on a-haemolysin production were determined using haemolysis, Western blot and real-time RT-PCR assays. The viability and cytotoxicity assays were performed to evaluate the influence of PNCB on a-toxin-mediated injury of human alveolar epithelial cells. Moreover, through histopathologic analysis, we further determined the in vivo effects of PNCB on Staph. aureus pneumonia in a mouse model. In vitro, PNCB at low concentrations exhibited inhibitory activity against a-haemolysin production and attenuated a-haemolysinmediated cell injury. Furthermore, the in vivo findings demonstrated that PNCB protected mice from Staph. aureus pneumonia. Conclusions: We have provided new evidence of the effects of PNCB, which suggest that PNCB attenuated a-haemolysin-mediated cell injury and protected mice from Staph. aureus pneumonia. Significance and Impact of the Study: The findings indicate that PNCB may be used as a basis for anti-Staphylococcus agent.

The present study focuses on the neuroprotective effect of glycyrrhizic acid (GA, a major compound separated from Glycyrrhiza Radix, which is a crude Chinese traditional drug) against glutamate-induced cytotoxicity in differentiated PC12 (DPC12) cells. The results showed that GA treatment improved cell viability and ameliorated abnormal glutamate-induced alterations in mitochondria in DPC12 cells. GA reversed glutamate-suppressed B-cell lymphoma 2 levels, inhibited glutamate-enhanced expressions of Bax and cleaved caspase 3, and reduced cytochrome C (Cyto C) release. Exposure to glutamate strongly inhibited phosphorylation of AKT (protein kinase B) and extracellular signal-regulated kinases (ERKs); however, GA pretreatment enhanced activation of ERKs but not AKT. The presence of PD98059 (a mitogen-activated protein/extracellular signal-regulated kinase kinase [MEK] inhibitor) but not LY294002 (a phosphoinositide 3-kinase [PI3K] inhibitor) diminished the potency of GA for improving viability of glutamate-exposed DPC12 cells. These results indicated that ERKs and mitochondria-related pathways are essential for the neuroprotective effect of GA against glutamate-induced toxicity in DPC12 cells. The present study provides experimental evidence supporting GA as a potential therapeutic agent for use in the treatment of neurodegenerative diseases.

The use of transition metal oxides and hydroxides in supercapacitors can yield high specific capacity electrodes. However, the effect of interaction between active material and current collector has remained unexplored. Here the behaviour of electrodeposited hexagonal cobalt hydroxide nanosheets on a variety of substrates was investigated, and the resulting valence bonding, morphological evolutions and phase transformations examined. It is shown that the electrochemical activity of the face centred cubic (FCC) Ni substrate dramatically decreases cyclability, the FCC Cu substrate also demonstrates decreased performance, and hexagonal carbon nanofibre (CNF) and Ti substrates exhibit far more stability. The miscellaneous roles of valence bonding, redox reactions and crystal structure mismatch between active material and current collector are examined, and their consequences discussed. Using the resulting insights into performance criteria, it was possible to select a suitable substrate for the fabrication of an asymmetric supercapacitor. The high performance and stability of the device demonstrates the usefulness of this approach, and the utility of applying these insights to energy storage devices.